The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090

By AHRMM

AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).

Related Resources

Case Studies
Centura Health’s Practice Variation Reduction Reduces Costs, Improves Quality, and Boosts Financial Outcomes
Organization Overview
Case Studies
Pharmacies Focused on Patients Instead of Prescriptions: the Community Pharmacy Enhanced Services Network
Organization Overview
Case Studies
Ochsner Health System Boosts Immunization Rates Among Ambulatory Patients
Organization Overview
Case Studies
University of Alabama at Birmingham (UAB) Medicine’s Post-Acute Care Strategy for Bundled Payments
Organization Overview
Case Studies
Intermountain Healthcare Drives Heart Healthiness Within Its Community
Organization Overview
Case Studies
Ochsner Health System’s Social Determinants of Health Program
Organization Overview